Roche Holding (Switzerland) Insiders
| ROG Stock | CHF 255.50 1.60 0.63% |
Roche Holding employs about 103.6 K people. The company is managed by 10 executives with a total tenure of roughly 241764 years, averaging almost 24176.0 years of service per executive, having 10361.3 employees per reported executive. Recap of Roche Holding's management performance can provide insight into the venture performance.
| Claudia Bockstiegel Insider G Counsel |
| Barbara Schadler Insider Head Communications |
Roche |
Roche Holding Management Team Effectiveness
The company has return on total asset (ROA) of 0.1468 % which means that it generated a profit of $0.1468 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4483 %, meaning that it generated $0.4483 on every $100 dollars invested by stockholders. Roche Holding's management efficiency ratios could be used to measure how well Roche Holding manages its routine affairs as well as how well it operates its assets and liabilities.Roche Holding Workforce Comparison
Roche Holding AG is currently regarded as top stock in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is at this time estimated at about 624,195. Roche Holding retains roughly 103,613 in number of employees claiming about 17% of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.19 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32. Roche Holding AG Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Roche Holding AG Price Series Summation is a cross summation of Roche Holding price series and its benchmark/peer.
Roche Holding Notable Stakeholders
A Roche Holding stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Roche Holding often face trade-offs trying to please all of them. Roche Holding's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Roche Holding's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Claudia Bockstiegel | G Counsel | Profile | |
| Barbara Schadler | Head Communications | Profile | |
| Johannes MD | Head Devel | Profile | |
| Bruno Eschli | Head Relations | Profile | |
| Thomas Schinecker | Chief Diagnostics | Profile | |
| Cristina Wilbur | Chief Officer | Profile | |
| William Anderson | Chief Pharmaceuticals | Profile | |
| Alan Hippe | Chief Officer | Profile | |
| Severin Schwan | CEO Director | Profile | |
| Pascale Schmidt | Chief Officer | Profile |
About Roche Holding Management Performance
The success or failure of an entity such as Roche Holding AG often depends on how effective the management is. Roche Holding management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Roche management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Roche management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE GS operates under Drug ManufacturersGeneral classification in Switzerland and is traded on Switzerland Exchange. It employs 100920 people.
Please note, the imprecision that can be found in Roche Holding's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Roche Holding AG. Check Roche Holding's Beneish M Score to see the likelihood of Roche Holding's management manipulating its earnings.
Roche Holding Workforce Analysis
Traditionally, organizations such as Roche Holding use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Roche Holding within its industry.Roche Holding Manpower Efficiency
Return on Roche Holding Manpower
| Revenue Per Employee | 606.1K | |
| Revenue Per Executive | 6.3B | |
| Net Income Per Employee | 134.4K | |
| Net Income Per Executive | 1.4B |
Additional Tools for Roche Stock Analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.